The advent of human diploid cell rabies vaccine: impact on vaccine utilization in New Mexico.
- 1 April 1981
- journal article
- research article
- Published by American Public Health Association in American Journal of Public Health
- Vol. 71 (4), 423-424
- https://doi.org/10.2105/ajph.71.4.423
Abstract
Three months' experience with the newly licensed human diploid cell rabies vaccine in the New Mexico comprehensive consultation-biologics system was reviewed. Comparison with the same period in 1978 and 1979 showed no increase in vaccine utilization despite the advent of this simpler-to-use, safer rabies vaccine. Anti-rabies treatments appear to be minimally influenced by new vaccine technology when a comprehensive consultation system is available to support and guide the private physician.This publication has 5 references indexed in Scilit:
- Postexposure Trial of a Human Diploid Cell Strain Rabies VaccineThe Journal of Infectious Diseases, 1980
- Anti-rabies treatments in New Mexico: impact of a comprehensive consultation-biologics system.American Journal of Public Health, 1980
- Successful protection of humans exposed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antirabies serumJAMA, 1976
- Adverse Reactions to Duck Embryo Rabies VaccineAnnals of Internal Medicine, 1973